Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)

SHE:003017 Revenue

Zhe Jiang Dayang Biotech Group had revenue of 280.76M CNY in the quarter ending June 30, 2026, with 12.15% growth. This brings the company's total for the last twelve months to 1.11B, up 13.68% year-over-year. In the year 2025, Zhe Jiang Dayang Biotech Group had annual revenue of 1.05B with 14.89% growth. That makes Zhe Jiang Dayang Biotech Group the 18,863rd largest company in the world by revenue and 3,438th in China.

• Revenue (ttm): 1.11B
• Revenue Growth: +13.68%
• P/S Ratio: 1.98
• Revenue / Employee: 1.43M
• Employees: 771
• Market Cap: 2.19B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chemical Products 978.83M 93.6%
• Others 66.61M 6.4%

By Geography

Chart

• China 835.77M 79.9%
• Overseas 209.67M 20.1%

Fiscal year ended Dec 31, 2025 See the full SHE:003017 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.05B	135.48M	14.89%
Dec 31, 2024	909.96M	-9.50M	-1.03%
Dec 31, 2023	919.45M	-138.65M	-13.10%
Jan 1, 2023	1.06B	274.90M	35.10%
Dec 31, 2021	783.21M	104.87M	15.46%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error